发明申请
US20100190822A1 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
失效
药物组合物作为二肽基肽酶-IV（DPP-IV）的抑制剂
- 专利标题： Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
- 专利标题（中）： 药物组合物作为二肽基肽酶-IV（DPP-IV）的抑制剂
-
申请号： US12727558申请日： 2010-03-19
-
公开(公告)号： US20100190822A1公开(公告)日： 2010-07-29
- 发明人: David J. Madar , Stevan W. Djuric , Melissa J. Michmerhuizen , Hana A. Kopecka , Xiaofeng Li , Kenton L. Longenecker , Zhonghua Pei , Daisy Pireh , Hing L. Sham , Kent D. Stewart , Bruce G. Szczepankiewicz , Paul E. Wiedeman , Hong Yong
- 申请人： David J. Madar , Stevan W. Djuric , Melissa J. Michmerhuizen , Hana A. Kopecka , Xiaofeng Li , Kenton L. Longenecker , Zhonghua Pei , Daisy Pireh , Hing L. Sham , Kent D. Stewart , Bruce G. Szczepankiewicz , Paul E. Wiedeman , Hong Yong
- 申请人地址： US IL Abbott Park
- 专利权人： ABBOTT LABORATORIES
- 当前专利权人： ABBOTT LABORATORIES
- 当前专利权人地址： US IL Abbott Park
- 主分类号： A61K31/4725
- IPC分类号： A61K31/4725 ; C07D207/16 ; A61K31/40 ; A61P3/10 ; A61P3/04 ; A61P3/08 ; C07D401/08 ; C07D401/14 ; A61K31/4545 ; C07D401/12 ; A61K31/454 ; A61K31/4439 ; C07D403/08 ; A61K31/4025
摘要：
The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
公开/授权文献
信息查询
IPC分类:
